Target intelligence / Profile preview

Thioredoxin like 1 pseudogene 1 (TXNL1P1)

Target
TXNL1P1
Molecular classification
Other (pseudogene)
01

Overview

Thioredoxin like 1 pseudogene 1 (TXNL1P1) is classified as a pseudogene. Pseudogenes are DNA segments with high sequence homology to a functional gene, in this case *thioredoxin like 1*, but are rendered non-functional and incapable of producing a protein due to disabling mutations or loss of regulatory elements[1][4]. They do not serve the molecular or therapeutic functions of active protein-coding genes and are not considered receptors, enzymes, or therapeutic targets. Although in rare circumstances some pseudogenes may influence the expression of their parent gene at the RNA level, there is no evidence for such functional regulatory activity or disease association specific to TXNL1P1. Key Points: - TXNL1P1 is *not* a gene product, receptor, enzyme, or classic drug target. - It is a **non-functional pseudogene** by current genomic nomenclature standards[4]. - No drug interactions, disease associations, biological functions, or safety/biomarker considerations are established for this entity.

Other names
TXNL1P1
02

Biological functions

Other (pseudogenes generally lack direct biological function, though some may regulate their parent gene at the RNA level in rare cases)
03

Disease associations

Other (pseudogenes may sometimes be implicated in rare gene regulatory or evolutionary contexts, but there is no known disease association for TXNL1P1)

Beyond the preview

Go deeper on Thioredoxin like 1 pseudogene 1 (TXNL1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thioredoxin like 1 pseudogene 1 (TXNL1P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call